Clinical Trials Logo
  1. Home
  2. Obesity
  3. NCT03570034
  4. Details
NCT03570034 Clinical Trial

Obalon Balloon System Post-Approval Study

Obesity Clinical Trial

— PAS  

Official title:
Obalon Balloon System - Post-Approval Study

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT03570034
Other study ID # PTL-7500-0011
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date June 15, 2018
Est. completion date March 13, 2021

Study information
Verified date April 2020
Source Obalon Therapeutics, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The Obalon Balloon System - Post-Approval Study is a prospective, observational, and multi-center study.

Description:

The Obalon PAS is a 1-year study that includes 6-month of Obalon Balloon therapy in conjunction of a weight loss behavior modification (WLBM) program and 6-month of continued WLBM program after balloon removal

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 201
Est. completion date March 13, 2021
Est. primary completion date September 13, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 22 Years and older
Eligibility Inclusion Criteria:

- At least 22 years old

- BMI of 30-40 kg/m2

Exclusion Criteria:

- Contraindicated for the device

- Use of medications or medical devices known to induce weight gain or weight loss within the preceding 6 months.

- Known history of endocrine disorders affecting weight.

- Participation in any clinical study which could affect weight loss within the past year

- Known history or present condition of structural or functional disorders of the esophagus that may impede passage of the device through the gastrointestinal tract, including, Barrett's esophagus, esophagitis, dysphagia, achalasia, stricture/stenosis, esophageal varices, diverticula, or any other disorder of the esophagus

- Life expectancy less than 1 year or severe renal, hepatic, pulmonary or other medical condition, in the opinion of the investigator

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Obalon Balloon System
Obalon Balloon System with a moderate intensity Weight Loss Behavioral Modification Program

Locations
Country Name City State
United States University of Colorado Denver Aurora Colorado
United States JourneyLite Physicians Cincinnati Ohio
United States Minimally Invasive Surgical Associates Dallas Texas
United States Snow Bariatic Center Flower Mound Texas
United States Ultimate Bariatrics Fort Worth Texas
United States Smart Dimensions Weight Loss Fountain Valley California
United States Davtyan Medical Weight Loss and Wellness Glendale California
United States Lifetime Surgical Weight Loss Los Gatos California
United States Surgical Specialists of Louisiana Metairie Louisiana
United States Greenwich Village Gastroenterology Poughkeepsie New York
United States New York Bariatric Group Roslyn Heights New York
United States Bariatric Medical Institute of Texas San Antonio Texas
United States SkyLex Health Santa Monica California
United States New Jersey Bariatric Center Springfield New Jersey
United States Artisan Cosmetic Surgery Toledo Ohio

Sponsors (1)
Lead Sponsor Collaborator
Obalon Therapeutics, Inc.

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Serious Adverse Event Device or Procedure related Serious Adverse Event 6-Month
Primary Percentage of Patients with at least 5% TBWL Percentage of Patients with at least 5% TBWL 6-Month
Primary Mean % TBWL Mean %TBWL 6-Month
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2